Study finds way to ‘reboot’ eye and restore impaired vision

Groundbreaking study finds way to ‘reboot’ eye and restore impaired vision - Findings may lead to new treatment for ‘lazy eye ...

Regeneron Gets FDA Approval for Eye Treatment Eylea

The approval is for Eylea to treat macular edema following retinal vein occlusion with up to every eight-week dosing after an initial dosing period. The FDA also approved a monthly dosing option for ...

EYLEA HD® (aflibercept) Injection 8 mg Approved by FDA for the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing Across Approved Indications

First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing ...